CD56 is another marker, constitutively expressed by circulating normal NK cells and usually downregulated in CLPD-NK; its expression in T-LGLL may be associated with a less-favorable prognosis (2, 3). This evidence concerns the gene NCAM1 and T-cell large granular lymphocyte leukemia.